$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | CCXI | ChemoCentryx, Inc. | Butt Tausif | EVP, Chief Operatin ... | Option Exercise | A | 13.17 | 75,000 | 987,750 | 75,000 | |
May 24 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | A | 10.06 | 4,504 | 45,310 | 4,504 | |
May 24 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Grant | A | 0.00 | 7,726 | 0 | 127,583 | 119.9 K to 127.6 K (+6.45 %) |
May 10 2021 | CCXI | ChemoCentryx, Inc. | Butt Tausif | EVP, Chief Operatin ... | Buy | P | 11.06 | 10,870 | 120,241 | 10,870 | 0 to 10.9 K |
Mar 30 2021 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | M | 0.00 | 5,251 | 0 | 5,251 | |
Mar 30 2021 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Buy | M | 0.00 | 5,251 | 0 | 18,226 | 13 K to 18.2 K (+40.47 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 55.89 | 13,330 | 744,974 | 12,690 | 26 K to 12.7 K (-51.23 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 56.78 | 16,670 | 946,494 | 26,020 | 42.7 K to 26 K (-39.05 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 60.20 | 1,910 | 114,980 | 42,690 | 44.6 K to 42.7 K (-4.28 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 16,008 | 176,408 | 42,292 | |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 10.86 | 11,667 | 126,704 | 24,792 | |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.62 | 5,417 | 35,861 | 18,958 | |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 69.09 | 5,359 | 370,235 | 85,826 | 91.2 K to 85.8 K (-5.88 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 68.51 | 20,680 | 1,416,847 | 91,185 | 111.9 K to 91.2 K (-18.49 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 67.68 | 7,053 | 477,362 | 111,865 | 118.9 K to 111.9 K (-5.93 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 16,008 | 176,408 | 118,918 | 102.9 K to 118.9 K (+15.56 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 10.86 | 11,667 | 126,704 | 102,910 | 91.2 K to 102.9 K (+12.79 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.62 | 5,417 | 35,861 | 91,243 | 85.8 K to 91.2 K (+6.31 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 70.08 | 600 | 42,048 | 119,857 | 120.5 K to 119.9 K (-0.50 %) |
Mar 03 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 70.03 | 500 | 35,015 | 120,457 | 121 K to 120.5 K (-0.41 %) |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 65.87 | 54,600 | 3,596,502 | 54,600 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 79,000 | 0 | 79,000 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 65.87 | 21,700 | 1,429,379 | 21,700 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 0.00 | 31,400 | 0 | 31,400 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 65.87 | 13,500 | 889,245 | 13,500 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 0.00 | 19,500 | 0 | 19,500 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Butt Tausif | EVP, Chief Operatin ... | Option Exercise | A | 65.87 | 87,000 | 5,730,690 | 87,000 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 9.04 | 833 | 7,530 | 25,834 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 1,125 | 12,398 | 24,750 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.86 | 1,389 | 15,085 | 13,897 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | A | 65.87 | 16,640 | 1,096,077 | 16,640 | |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 68.89 | 1,817 | 125,166 | 3,232 | 5 K to 3.2 K (-35.99 %) |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 68.08 | 1,530 | 104,169 | 5,049 | 6.6 K to 5 K (-23.26 %) |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 9.04 | 833 | 7,530 | 6,579 | 5.7 K to 6.6 K (+14.50 %) |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 1,125 | 12,398 | 5,746 | 4.6 K to 5.7 K (+24.35 %) |
Mar 01 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.86 | 1,389 | 15,085 | 4,621 | 3.2 K to 4.6 K (+42.98 %) |
Feb 11 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 700 | 7,714 | 58,300 | |
Feb 11 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 69.66 | 700 | 48,765 | 85,826 | 86.5 K to 85.8 K (-0.81 %) |
Feb 11 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 700 | 7,714 | 86,526 | 85.8 K to 86.5 K (+0.82 %) |
Feb 11 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 70.04 | 400 | 28,014 | 120,957 | 121.4 K to 121 K (-0.33 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 7,420 | 81,768 | 59,000 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 805 | 8,871 | 66,420 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 1,400 | 15,428 | 67,225 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 68.00 | 200 | 13,600 | 85,826 | 86 K to 85.8 K (-0.23 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 67.28 | 7,220 | 485,751 | 86,026 | 93.2 K to 86 K (-7.74 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 7,420 | 81,768 | 93,246 | 85.8 K to 93.2 K (+8.65 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 67.07 | 805 | 53,994 | 85,826 | 86.6 K to 85.8 K (-0.93 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 805 | 8,871 | 86,631 | 85.8 K to 86.6 K (+0.94 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 67.14 | 1,400 | 93,995 | 85,826 | 87.2 K to 85.8 K (-1.61 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 1,400 | 15,428 | 87,226 | 85.8 K to 87.2 K (+1.63 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 9.04 | 833 | 7,530 | 26,667 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 1,125 | 12,398 | 25,875 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.86 | 1,389 | 15,085 | 15,286 | |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 65.00 | 3,347 | 217,555 | 3,232 | 6.6 K to 3.2 K (-50.87 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 9.04 | 833 | 7,530 | 6,579 | 5.7 K to 6.6 K (+14.50 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 1,125 | 12,398 | 5,746 | 4.6 K to 5.7 K (+24.35 %) |
Feb 08 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.86 | 1,389 | 15,085 | 4,621 | 3.2 K to 4.6 K (+42.98 %) |
Feb 04 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 61.29 | 7,983 | 489,317 | 121,357 | 129.3 K to 121.4 K (-6.17 %) |
Feb 04 2021 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 60.71 | 12,017 | 729,527 | 129,340 | 141.4 K to 129.3 K (-8.50 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 11.02 | 1,375 | 15,153 | 68,625 | |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 67.03 | 1,375 | 92,172 | 85,826 | 87.2 K to 85.8 K (-1.58 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 11.02 | 1,375 | 15,153 | 87,201 | 85.8 K to 87.2 K (+1.60 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 9.04 | 834 | 7,539 | 27,500 | |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 1,125 | 12,398 | 27,000 | |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.86 | 1,391 | 15,106 | 16,675 | |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 6.62 | 834 | 5,521 | 0 | |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 65.00 | 4,184 | 271,960 | 3,232 | 7.4 K to 3.2 K (-56.42 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 9.04 | 834 | 7,539 | 7,416 | 6.6 K to 7.4 K (+12.67 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 1,125 | 12,398 | 6,582 | 5.5 K to 6.6 K (+20.62 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.86 | 1,391 | 15,106 | 5,457 | 4.1 K to 5.5 K (+34.21 %) |
Jan 27 2021 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 6.62 | 834 | 5,521 | 4,066 | 3.2 K to 4.1 K (+25.80 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 34,566 | 0 | 69,134 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 23,333 | 0 | 23,334 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 61.92 | 47,576 | 2,945,906 | 2,308,880 | 2.4 M to 2.3 M (-2.02 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 34,566 | 0 | 2,356,456 | 2.3 M to 2.4 M (+1.49 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 23,333 | 0 | 2,321,890 | 2.3 M to 2.3 M (+1.02 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,298,557 | 2.3 M to 2.3 M (+1.32 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,333 | 0 | 20,667 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 61.92 | 16,498 | 1,021,556 | 118,765 | 135.3 K to 118.8 K (-12.20 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,333 | 0 | 135,263 | 124.9 K to 135.3 K (+8.27 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 124,930 | 114.9 K to 124.9 K (+8.70 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 114,930 | 104.9 K to 114.9 K (+9.53 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 7,766 | 0 | 15,534 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,667 | 0 | 6,667 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 61.92 | 11,521 | 713,380 | 85,826 | 97.3 K to 85.8 K (-11.83 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 7,766 | 0 | 97,347 | 89.6 K to 97.3 K (+8.67 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,667 | 0 | 89,581 | 82.9 K to 89.6 K (+8.04 %) |
Jan 07 2021 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,667 | 0 | 82,914 | 76.2 K to 82.9 K (+8.74 %) |
Dec 29 2020 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 61.50 | 10,782 | 663,093 | 141,357 | 152.1 K to 141.4 K (-7.09 %) |
Dec 29 2020 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Sell | S | 61.18 | 14,218 | 869,904 | 152,139 | 166.4 K to 152.1 K (-8.55 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 17,619 | 252,128 | 6,988 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 11,153 | 159,599 | 24,607 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.01 | 17,619 | 1,145,450 | 2,268,557 | 2.3 M to 2.3 M (-0.77 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 17,619 | 252,128 | 2,286,176 | 2.3 M to 2.3 M (+0.78 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 65.03 | 11,153 | 725,246 | 2,268,557 | 2.3 M to 2.3 M (-0.49 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 11,153 | 159,599 | 2,279,710 | 2.3 M to 2.3 M (+0.49 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 9.04 | 11,666 | 105,461 | 28,334 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 10,919 | 120,327 | 28,125 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 1,456 | 16,045 | 39,044 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.86 | 16,675 | 181,091 | 18,066 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 6.62 | 3,333 | 22,064 | 834 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 6.62 | 6,667 | 44,136 | 4,167 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 3.57 | 834 | 2,977 | 0 | |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 65.06 | 42,593 | 2,771,237 | 3,232 | 45.8 K to 3.2 K (-92.95 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 9.04 | 11,666 | 105,461 | 45,825 | 34.2 K to 45.8 K (+34.15 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.86 | 16,675 | 181,091 | 34,159 | 17.5 K to 34.2 K (+95.37 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 10,919 | 120,327 | 17,484 | 6.6 K to 17.5 K (+166.32 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 6.62 | 3,333 | 22,064 | 6,565 | 3.2 K to 6.6 K (+103.13 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 65.02 | 8,957 | 582,398 | 3,232 | 12.2 K to 3.2 K (-73.48 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 1,456 | 16,045 | 12,189 | 10.7 K to 12.2 K (+13.57 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 6.62 | 6,667 | 44,136 | 10,733 | 4.1 K to 10.7 K (+163.97 %) |
Dec 16 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 3.57 | 834 | 2,977 | 4,066 | 3.2 K to 4.1 K (+25.80 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.58 | 16,650 | 908,807 | 9,194,085 | 9.2 M to 9.2 M (-0.18 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.62 | 31,823 | 1,706,308 | 9,210,735 | 9.2 M to 9.2 M (-0.34 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 52.92 | 785 | 41,540 | 9,242,558 | 9.2 M to 9.2 M (-0.01 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.33 | 694 | 37,704 | 9,243,343 | 9.2 M to 9.2 M (-0.01 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 52.57 | 29,699 | 1,561,253 | 9,244,037 | 9.3 M to 9.2 M (-0.32 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 51.74 | 10,009 | 517,868 | 9,273,736 | 9.3 M to 9.3 M (-0.11 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.85 | 22,467 | 1,232,283 | 9,283,745 | 9.3 M to 9.3 M (-0.24 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.43 | 24,458 | 1,331,354 | 9,306,212 | 9.3 M to 9.3 M (-0.26 %) |
Aug 03 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.37 | 1,156 | 61,692 | 9,330,670 | 9.3 M to 9.3 M (-0.01 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.15 | 2,363 | 125,595 | 9,331,826 | 9.3 M to 9.3 M (-0.03 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 52.69 | 76,321 | 4,021,361 | 9,334,189 | 9.4 M to 9.3 M (-0.81 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 51.51 | 9,328 | 480,524 | 9,410,510 | 9.4 M to 9.4 M (-0.10 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.18 | 6,790 | 367,896 | 9,419,838 | 9.4 M to 9.4 M (-0.07 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.38 | 33,370 | 1,781,221 | 9,426,628 | 9.5 M to 9.4 M (-0.35 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.66 | 10,790 | 578,953 | 9,459,998 | 9.5 M to 9.5 M (-0.11 %) |
Jul 29 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.17 | 23,446 | 1,246,523 | 9,470,788 | 9.5 M to 9.5 M (-0.25 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.58 | 400 | 21,430 | 9,494,234 | 9.5 M to 9.5 M (0.00 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 52.86 | 9,961 | 526,544 | 9,494,634 | 9.5 M to 9.5 M (-0.10 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 52.31 | 15,689 | 820,762 | 9,504,595 | 9.5 M to 9.5 M (-0.16 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.19 | 900 | 50,567 | 9,520,284 | 9.5 M to 9.5 M (-0.01 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.78 | 6,055 | 337,733 | 9,521,184 | 9.5 M to 9.5 M (-0.06 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 54.50 | 5,452 | 297,155 | 9,527,239 | 9.5 M to 9.5 M (-0.06 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 53.54 | 22,148 | 1,185,842 | 9,532,691 | 9.6 M to 9.5 M (-0.23 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.85 | 23,441 | 1,309,124 | 9,554,839 | 9.6 M to 9.6 M (-0.24 %) |
Jul 24 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.45 | 49,028 | 2,718,745 | 9,578,280 | 9.6 M to 9.6 M (-0.51 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.20 | 6,263 | 351,977 | 9,627,308 | 9.6 M to 9.6 M (-0.07 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.44 | 81,266 | 4,505,655 | 9,633,571 | 9.7 M to 9.6 M (-0.84 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.18 | 37,596 | 2,111,989 | 9,714,837 | 9.8 M to 9.7 M (-0.39 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.70 | 17,002 | 947,064 | 9,752,433 | 9.8 M to 9.8 M (-0.17 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.03 | 117 | 6,673 | 9,769,435 | 9.8 M to 9.8 M (0.00 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 56.58 | 22,196 | 1,255,876 | 9,769,552 | 9.8 M to 9.8 M (-0.23 %) |
Jul 21 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 55.23 | 25,577 | 1,412,556 | 9,791,748 | 9.8 M to 9.8 M (-0.26 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 58.55 | 6,471 | 378,868 | 9,817,325 | 9.8 M to 9.8 M (-0.07 %) |
Jul 16 2020 | CCXI | ChemoCentryx, Inc. | Vifor (International) Ltd | 10% Owner | Sell | S | 57.99 | 18,888 | 1,095,292 | 9,823,796 | 9.8 M to 9.8 M (-0.19 %) |